LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
LivaNova PLC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$78.14+0.56 (+0.72%)
Close on Oct 19, 2026
- Market cap
- $4.40B
- P/E (TTM)
- 23.1
- Dividend yield
- –
LivaNova PLC balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 68.1%
- Operating margin
- 12.7%
- Net margin
- 12.8%
- Return on equity, FY2025
- -19.2%
Financial strength
- Current ratio
- 1.45
- Debt to equity
- 0.22
- Debt to assets
- 11.1%
- Cash to current liabilities
- 73.1%
Valuation
- P/E ratio
- 23.1
- Price to sales
- 2.99
- Price to book
- 3.32
- Dividend yield
- –